全球学术和非营利组织的附属条款和协议（2019-2024）

本报告提供了有关公司与学术和非营利组织合作的原因和条件的详细资讯和分析。这些协议往往是多方面的，从联合研发开始，一直到成果的商业化。

本报告详细介绍了 2019 年以来生命科学领域宣布的 3,938 项学术和非营利协议。

该报告对学术和非营利性合约趋势、领先公司、主要合约金额和合约财务进行了全面回顾，您可以了解哪些组织正在与哪些组织签订合作协议。

本报告从财务角度评估学术和非营利组织的交易条款和价值，包括交易总额、预付款、里程碑和特许权使用费率等信息，以帮助读者了解交易的财务方面现在可以分析和比较的值。

本报告的中间部分考察了学术和非营利合作伙伴领域的领先交易撮合者。报告主要交易的交易价值以及学术和非营利组织中最活跃的交易撮合者，让读者了解哪些公司在这个充满活力的交易市场中取得了成功。

学术和非营利组织的线上交易记录包含在本报告末尾，采用以下目录格式：

• 公司名称（A-Z）
• 发展阶段
• 交易类型
• 治疗重点领域
• 技术类型
• 此外，我们也会记录公司及其关联公司向美国证券交易委员会提交的合约文件（如果有）。虽然许多公司想要详细的付款条款，但在付款方式方面，细节才是王道，而合约文件可以提供新闻稿和资料库所无法提供的洞察力。
• 本报告也包含一些图表，显示 2019 年以来学术和非营利合作与交易的趋势和动态。
• 总而言之，本报告提供了未来交易撮合者需要了解的有关学术和非营利性研究、开发和商业化合作伙伴关係的所有资讯。

主要优点

该报告为读者提供了以下主要好处：

• 有关学术和非营利组织合约趋势的详细资讯（2019 年及以后）
• 取得交易金额、预付款、里程碑和版税率数据
• 学术和非营利组织与主要生物製药公司签署的实际协议：查看详细信息
• 确定学术和非营利组织中最活跃的交易撮合者（2019 年及以后）
• 公司过去同意的主要合约条件的说明
• 进行尽职调查：评估向合作伙伴公司提出的合约条款的适当性

调查范围

• 本报告旨在让读者深入了解和了解学术和非营利组织的趋势和结构以及世界领先公司进行的交易。

学术和非营利组织合作条件和合约详细资讯：

• 生物製药产业的学术和非营利组织交易趋势（2019 年及以后）
• 取得交易金额、预付款、里程碑和版税率数据
• 取得主要製药公司的合约文件
• 与主要学术和非营利组织的交易金额（2019 年起）
• 学术界和非营利组织最活跃的交易撮合者（2019 年起）

此报告列出了可用合约的以下资讯：

• 公司名称（A-Z）
• 总交易金额
• 合约签订时的开发阶段
• 合约组成部分的类型
• 具体治疗标靶
• 技术类型
• 每笔交易的标题都透过网路连结连结到交易记录的线上版本以及合约文件（如果有），从而可以轻鬆按需存取每份合约文件。

透过分析实际合同，可以评估：

• 授予或选择的具体权利是什么？
• 合约实际上赋予了合作伙伴公司什么？
• 授予哪些类型的专有权？
• 合约的付款结构是怎样的？
• 如何审核销售和付款？
• 条款和条件是什么？
• 合约的主要条款是如何定义的？
• 智慧财产权的处理和所有权如何？
• 谁负责商业化？
• 谁负责开发、供应和製造？
• 如何管理保密和发布？
• 如何解决争议？
• 什么情况下可以取消合约？
• 如果所有者发生变化会怎样？
• 已就何种类型的分授权或分包条款达成协议？
• 公司主张哪些样板条款？
• 根据合作伙伴关係或交易的类型，哪些样板条款看起来有所不同？
• 公司对契约法主张哪一个管辖权？

目录

摘要整理

第2章 学术及非营利团体的交易趋势

• 简介
• 学术及非营利团体的长期性的联盟趋势
• 在学术及非营利团体最活跃的交易商
• 学术及非营利团体的联盟趋势:各交易类型
• 学术及非营利团体的联盟趋势:各治疗领域
• 学术及非营利团体的联盟趋势:各技术种类
• 学术及非营利团体的联盟条件
  • 学术及非营利团体的联盟的交易总额
  • 学术及非营利团体的交易的预付款金
  • 学术及非营利团体的交易的里程金
  • 学术及非营利团体的特许权率

第三章学术与非营利组织的重大交易

• 简介
• 学术和非营利组织的主要交易：交易金额

第 4 章学术与非营利组织中最活跃的交易撮合者

• 简介
• 学术和非营利组织中最活跃的交易撮合者
• 最活跃的学术和非营利合作伙伴：简介

第五章学术与非营利组织的合约交易清单

• 简介
• 学术和非营利组织合约交易列表

第 6 章学术与非营利组织交易趋势：依技术类型划分

附录

Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of 3,938 Academic and Non-Profit agreements announced in the life sciences since 2019.

The report takes the reader through a comprehensive review Academic and Non-Profit deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Academic and Non-Profit partnering deals.

The report presents financial deal term values for Academic and Non-Profit deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Academic and Non-Profit partnering field; both the leading deal values and most active Academic and Non-Profit dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

Online deal records of Academic and Non-Profit deals are included towards the end of the report in a directory format by:

• Company A-Z
• Stage of development
• Deal type
• Therapy focus
• Technology type
• In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
• The initial chapters of this report provide an orientation of Academic and Non-Profit dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Academic and Non-Profit dealmaking since 2019, including details of headline, upfront, milestone and royalty terms.
• Chapter 3 provides a review of the leading Academic and Non-Profit deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
• Chapter 4 provides a comprehensive listing of the top 25 most active companies in Academic and Non-Profit dealmaking with a brief summary followed by a comprehensive listing of Academic and Non-Profit deals announded by that company, as well as contract documents, where available.
• Chapter 5 provides a comprehensive and detailed review of Academic and Non-Profit partnering deals signed and announced since Jan 2019, where a contract document is available in the public domain. Each deal title links via hyperlink to an online version of the deal record and contract document, providing easy access to each contract document on demand.
• Chapter 6 provides a comprehensive and detailed review of Academic and Non-Profit partnering deals signed and announced since Jan 2019. The chapter is organized by specific technology type. Each deal title links via hyperlink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.
• A comprehensive series of appendices is provided organized by Academic and Non-Profit partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via hyperlinkto an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.
• The report also includes numerous tables and figures that illustrate the trends and activities in Academic and Non-Profit partnering and dealmaking since 2019.
• In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Academic and Non-Profit technologies and products.

Key benefits

Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 provides the reader with the following key benefits:

• In-depth understanding of Academic and Non-Profit deal trends since 2019
• Access to headline, upfront, milestone and royalty data
• Detailed access to actual Academic and Non-Profit contracts entered into by leading biopharma companies
• Identify most active Academic and Non-Profit dealmakers since 2019
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

• Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 is intended to provide the reader with an in-depth understanding and access to Academic and Non-Profit trends and structure of deals entered into by leading companies worldwide.

Academic and Non-Profit Partnering Terms and Agreements includes:

• Trends in Academic and Non-Profit dealmaking in the biopharma industry since 2019
• Access to headline, upfront, milestone and royalty data
• Access to Academic and Non-Profit contract documents
• Leading Academic and Non-Profit deals by value since 2019
• Most active Academic and Non-Profit dealmakers since 2019

In Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024, the available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Technology type
• Each deal title links via hyperlink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Analyzing actual contract agreements allows assessment of the following:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Academic and Non-Profit dealmaking

• 2.1. Introduction
• 2.2. Academic and Non-Profit partnering over the years
• 2.3. Most active Academic and Non-Profit dealmakers
• 2.4. Academic and Non-Profit partnering by deal type
• 2.5. Academic and Non-Profit partnering by therapy area
• 2.6. Academic and Non-Profit partnering by technology type
• 2.7. Deal terms for Academic and Non-Profit partnering
  • 2.7.1 Academic and Non-Profit partnering headline values
  • 2.7.2 Academic and Non-Profit deal upfront payments
  • 2.7.3 Academic and Non-Profit deal milestone payments
  • 2.7.4 Academic and Non-Profit royalty rates

Chapter 3 - Leading Academic and Non-Profit deals

• 3.1. Introduction
• 3.2. Top Academic and Non-Profit deals by value

Chapter 4 - Most active Academic and Non-Profit dealmakers

• 4.1. Introduction
• 4.2. Most active Academic and Non-Profit dealmakers
• 4.3. Most active Academic and Non-Profit partnering company profiles

Chapter 5 - Academic and Non-Profit contracts dealmaking directory

• 5.1. Introduction
• 5.2. Academic and Non-Profit contracts dealmaking directory

Chapter 6 - Academic and Non-Profit dealmaking by technology type

Appendices

• Appendix 1 - Academic and Non-Profit deals by company A-Z
• Appendix 2 - Academic and Non-Profit deals by stage of development
• Appendix 3 - Academic and Non-Profit deals by deal type
• Appendix 4 - Academic and Non-Profit deals by therapy area
• Appendix 5 - Deal type definitions
• Appendix 6 - Further reading
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Academic/Non-Profit partnering since 2019
• Figure 2: Active Academic/Non-Profit dealmaking activity 2019-2024
• Figure 3: Academic/Non-Profit partnering by deal type since 2019
• Figure 4: Academic/Non-Profit partnering by disease type since 2019
• Figure 5: Academic/Non-Profit partnering by technology type since 2019
• Figure 6: Academic/Non-Profit deals with a headline value
• Figure 7: Academic/Non-Profit deals with an upfront value
• Figure 8: Academic/Non-Profit deals with a milestone value
• Figure 9: Academic/Non-Profit deals with a royalty rate value
• Figure 10: Top Academic/Non-Profit deals by value since 2019
• Figure 11: Most active Academic/Non-Profit dealmakers 2019-2024